PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY APPLICATION • Market segmentation by application • Comparison by application • Infants - Market size and forecast 2018-2023 • Adults - Market size and forecast 2018-2023 • Market opportunity by application PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Advanced Instruments • Danaher • F. Hoffmann-La Roche Ltd • Koninklijke Philips N.V. • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Application - Market share 2018-2023 (%) Exhibit 18: Comparison by application Exhibit 19: Infants - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Infants - Year-over-year growth 2019-2023 (%) Exhibit 21: Adults - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Adults - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by application Exhibit 24: Customer landscape Exhibit 25: Market share by geography 2018-2023 (%) Exhibit 26: Geographic comparison Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 28: North America - Year-over-year growth 2019-2023 (%) Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 30: Europe - Year-over-year growth 2019-2023 (%) Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Asia - Year-over-year growth 2019-2023 (%) Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Mortality rate for neonatal jaundice per 100,000 people (2016) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Impact of drivers and challenges Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Advanced Instruments - Vendor overview Exhibit 45: Advanced Instruments - Business segments Exhibit 46: Advanced Instruments - Organizational developments Exhibit 47: Advanced Instruments - Key offerings Exhibit 48: Danaher - Vendor overview Exhibit 49: Danaher - Business segments Exhibit 50: Danaher - Organizational developments Exhibit 51: Danaher - Geographic focus Exhibit 52: Danaher - Segment focus Exhibit 53: Danaher - Key offerings Exhibit 54: F. Hoffmann-La Roche Ltd - Vendor overview Exhibit 55: F. Hoffmann-La Roche Ltd - Business segments Exhibit 56: F. Hoffmann-La Roche Ltd - Organizational developments Exhibit 57: F. Hoffmann-La Roche Ltd - Geographic focus Exhibit 58: F. Hoffmann-La Roche Ltd - Segment focus Exhibit 59: F. Hoffmann-La Roche Ltd - Key offerings Exhibit 60: Koninklijke Philips N.V. - Vendor overview Exhibit 61: Koninklijke Philips N.V. - Business segments Exhibit 62: Koninklijke Philips N.V. - Organizational developments Exhibit 63: Koninklijke Philips N.V. - Geographic focus Exhibit 64: Koninklijke Philips N.V. - Segment focus Exhibit 65: Koninklijke Philips N.V. - Key offerings Exhibit 66: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 67: Thermo Fisher Scientific Inc. - Business segments Exhibit 68: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 69: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 70: Thermo Fisher Scientific Inc. - Segment focus Exhibit 71: Thermo Fisher Scientific Inc. - Key offerings Exhibit 72: Validation techniques employed for market sizing

Advanced Instruments Danaher F. Hoffmann-La Roche Ltd Koninklijke Philips N.V. Thermo Fisher Scientific Inc.